InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1 |
IXAQOQZEOGMIQS-SSQFXEBMSA-N |
CCCCC[C@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)CCCC(O)=O |
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via lipoxin )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via lipoxin )
|
|
View more via ChEBI Ontology
(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
|
(5S,6R,15S)-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
|
ChEBI
|
(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid
|
ChEBI
|
(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11,13-tetraenoic acid
|
ChEBI
|
(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid
|
KEGG COMPOUND
|
5(S),6(R),15(S)-trihydroxyeicosa-7E,9E,11Z,13E-tetraenoic acid
|
ChEBI
|
5S,6R,15S-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
|
ChEBI
|
5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
KEGG COMPOUND
|
5S,6R-LipoxinA4
|
LIPID MAPS
|
6R-LXA4
|
ChEBI
|
Lipoxin A4
|
KEGG COMPOUND
|
lipoxin A4
|
ChEBI
|
LXA4
|
KEGG COMPOUND
|
LXA4
|
ChEBI
|
4698639
|
Reaxys Registry Number
|
Reaxys
|
20435922
|
PubMed citation
|
Europe PMC
|
20802423
|
PubMed citation
|
Europe PMC
|
20833483
|
PubMed citation
|
Europe PMC
|
20950211
|
PubMed citation
|
Europe PMC
|
20959513
|
PubMed citation
|
Europe PMC
|
21263017
|
PubMed citation
|
Europe PMC
|
8690917
|
PubMed citation
|
Europe PMC
|
|